Cell tropism of adeno-associated viruses within the mouse inner ear in vivo: from embryonic to adult stages
- PMID: 40251388
- PMCID: PMC12008179
- DOI: 10.1038/s41598-025-98007-x
Cell tropism of adeno-associated viruses within the mouse inner ear in vivo: from embryonic to adult stages
Abstract
Adeno-associated virus (AAV)-based gene therapy is emerging as a promising treatment for deafness and vestibular deficits, due to the variety of available serotypes that offer a large range of cell targeting capabilities. Nevertheless, the tropism of these AAV serotypes for sensory inner ear cells varies greatly as the cochlea matures, presenting a significant burden for successful preclinical trials. Therefore, identifying serotypes with strong tropism for cochlear and vestibular hair cells during key stages of development in mouse inner ear, the most widely used preclinical model, is essential for advancing clinical applications. We conducted a comparative analysis of the cellular tropism and hair-cell transduction rates of four AAV serotypes in the cochlea and vestibular organs during maturation. We used AAV2, AAV8, AAV9-PHP.eB, and Anc80L65 at the embryonic, neonatal, and adult stages. Our results indicate that the cell transduction rate of these four serotypes varies with age. Notably outer hair cells were mostly targeted during the embryonic stage, inner hair cells were primarily transduced principally at the mature stage, and vestibular hair cells were the most permissive at the neonatal stage. These results provide new insights for preclinical gene therapy studies for the inner ear with potential implications for therapeutic outcomes.
Keywords: AAV; Gene therapy; Inner ear; Serotype; Therapeutic time window; Tropism.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Distributional comparison of different AAV vectors after unilateral cochlear administration.Gene Ther. 2024 Mar;31(3-4):154-164. doi: 10.1038/s41434-023-00431-z. Epub 2023 Dec 14. Gene Ther. 2024. PMID: 38097651
-
Delivery of Adeno-Associated Virus Vectors in Adult Mammalian Inner-Ear Cell Subtypes Without Auditory Dysfunction.Hum Gene Ther. 2018 Apr;29(4):492-506. doi: 10.1089/hum.2017.120. Epub 2018 Jan 22. Hum Gene Ther. 2018. PMID: 29130354 Free PMC article.
-
Efficient Delivery of Adeno-Associated Virus into Inner Ear In Vivo Through Trans-Stapes Route in Adult Guinea Pig.Hum Gene Ther. 2022 Jul;33(13-14):719-728. doi: 10.1089/hum.2021.236. Epub 2022 May 19. Hum Gene Ther. 2022. PMID: 35156857
-
Immune responses in the mammalian inner ear and their implications for AAV-mediated inner ear gene therapy.Hear Res. 2023 May;432:108735. doi: 10.1016/j.heares.2023.108735. Epub 2023 Mar 11. Hear Res. 2023. PMID: 36965335 Review.
-
In vivo tissue-tropism of adeno-associated viral vectors.Curr Opin Virol. 2016 Dec;21:75-80. doi: 10.1016/j.coviro.2016.08.003. Epub 2016 Sep 3. Curr Opin Virol. 2016. PMID: 27596608 Free PMC article. Review.
References
-
- Petit, C., Bonnet, C. & Safieddine, S. Deafness: from genetic architecture to gene therapy. Nat. Rev. Genet.24, 665–686 (2023). - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources